Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trial

Abstract Hot flashes (HF) are a common adverse event of prolonged tamoxifen use in women with estrogen receptor-positive breast cancer, impacting psychiatric health and quality carlsbad crush of life.While desvenlafaxine does not interact with tamoxifen, its efficacy and safety in breast cancer patients remain unstudied.This phase 3, four-week, mul

read more